Konstantin Poukalov

Affiliations

  • Chief Business Officer at Arya Sciences Acquisition Corp V (ARYE), 2021-07-12
  • Director at Lyra Therapeutics Inc. (LYRA), 2021-05-28
  • Chief Business Officer at Arya Sciences Acquisition Corp Iv (ARYD), 2021-02-26
  • Large Shareholder, Director at Landos Biopharma Inc. (LABP), 2021-02-10
  • Chief Business Officer at Arya Sciences Acquisition Corp Iii (ARYA), 2020-08-07
  • Chief Business Officer at Arya Sciences Acquisition Corp Ii (ARYB), 2020-06-05
  • Executive Vice President, Cfo at Kadmon Holdings Inc. (KDMN), 2017-12-12
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
LABP $14.60 34,951 Large Shareholder, Director 14,869,915 2021-02-09 Filing
LABP $13.80 64,730 Large Shareholder, Director 14,834,964 2021-02-09 Filing
LABP $13.10 1,771 Large Shareholder, Director 14,770,234 2021-02-08 Filing
LABP $12.53 86,671 Large Shareholder, Director 14,768,463 2021-02-08 Filing
LABP $11.38 34,611 Large Shareholder, Director 14,681,792 2021-02-08 Filing